Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.

Scientific reports - 14 Sept 2017

Hu Huimin, Wang Zheng, Li Mingyang, Zeng Fan, Wang Kuanyu, Huang Ruoyu, Wang Haoyuan, Yang Fan, Liang Tingyu, Huang Hua, Jiang Tao

Abstract excerpt

Malignant glioma is the most common brain cancer with dismal outcomes. Individual variation of the patients' survival times is remarkable. Here, we investigated the transcriptome and promoter methylation differences between patients of malignant glioma with short (less than one year) and the patients with long (more than three years) survival in CGGA (Chinese Glioma Genome Atlas), and validated the differences in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Gene Ontology

Share to Glioma

Share to Kaplan-Meier Estimate

Share to Neoplasm Grading

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 28912488
DOI: 10.1038/s41598-017-11962-y
PMCID: PMC5599690

Genes

DCTD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.PMID 28912488Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

The FDX1 methylation regulatory mechanism in the malignant phenotype of glioma.Semantic proximity Read ↗

Up-regulated Expression of MTHFD2 Correlates with Favorable Prognosis in LGG Patients: A Bioinformatic AnalysisSemantic proximity Read ↗

Bioinformatic identification of differentially expressed genes regulated by DNA‐methylation in glioblastomaSemantic proximity Read ↗

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.Semantic proximity Read ↗

DNA demethylation is associated with malignant progression of lower-grade gliomasSemantic proximity Read ↗

MRC2 overexpression combined with intronic hypomethylation: potential predictors for gliomaSemantic proximity Read ↗

Overexpression of MCM6 predicts poor survival in patients with gliomaSemantic proximity Read ↗

FoxD2-AS1is a prognostic factor in glioma and promotes temozolomide resistance in a O6-methylguanine-DNA methyltransferase-dependent mannerSemantic proximity Read ↗

Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.Semantic proximity Read ↗

The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.